Company Description
Hamilton Lane Incorporated is a private equity and venture capital firm specializing in early venture, emerging growth, turnaround, middle market, mature, mid-venture, bridge, buyout, distressed/vulture, loan, mezzanine in growth capital companies.
The firm manages alternative investment strategies like direct credit, direct, fund of fund, evergreen and real assets.
For primary and secondary fund of fund investments, the firm focuses to invest in private equity, buyout, special situations, credit, growth equity, middle market, mature, turnarounds, mezzanine and venture capital funds.
It prefers to invest in energy, industrials, commercial services, internet software & services, consumer discretionary, health care, real estate, information technology, tech-enabled businesses, financials, utilities, and consumer services.
The firm prefers to invest in Africa/Middle East, Asia/Pacific, Europe, Latin America and Caribbean, United States of America, California and surrounding states, Australia, Japan, United Kingdom, and Canada.
The firm prefers to invest between $1 million and $100 million in companies with small- to mid-sized enterprise values.
It prefers to take majority stake. Hamilton Lane Incorporated was founded in 1991 and is based in Conshohocken, Pennsylvania with additional offices across Europe, North America, Asia Pacific and the Middle East.
Country | United States |
Founded | 1991 |
IPO Date | Mar 1, 2017 |
Industry | Asset Management |
Sector | Financials |
Employees | 700 |
CEO | Erik R. Hirsch |
Contact Details
Address: 110 Washington Street, Suite 1300 Philadelphia, Pennsylvania 19428 United States | |
Phone | 610 934 2222 |
Website | hamiltonlane.com |
Stock Details
Ticker Symbol | HLNE |
Exchange | NASDAQ |
Fiscal Year | April - March |
Reporting Currency | USD |
CIK Code | 0001433642 |
CUSIP Number | 407497106 |
ISIN Number | US4074971064 |
Employer ID | 26-2482738 |
SIC Code | 6282 |
Key Executives
Name | Position |
---|---|
Dr. Juan M. Delgado-Moreira C.F.A., Ph.D. | Co-Chief Executive Officer and Member of the Board |
Erik R. Hirsch | Co-Chief Executive Officer and Member of the Board |
Mario Lucio Giannini J.D. | Executive Co-Chairman |
Andrea F. Kramer | Chief Operating Officer and Chief Risk Officer |
Jeffrey B. Armbrister | Chief Financial Officer and Treasurer |
Drew T. Carl CPA | MD and Chief Accounting Officer |
Hartley Raymond Rogers | Executive Co-Chairman |
Andrew Schardt | Vice Chairman, Head of Investment Strategy and Co-Head of Direct Equity |
Thomas J. Kerr | Co-Head of Investments and Co-Head of Secondary Investments |
Richard Hope | Head of EMEA and Co-Head of Investments |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Nov 14, 2024 | S-3ASR | Automatic shelf registration statement of securities of well-known seasoned issuers |
Nov 13, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
Nov 12, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
Nov 6, 2024 | 10-Q | Quarterly Report |
Nov 6, 2024 | 8-K | Current Report |
Nov 4, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
Oct 11, 2024 | 8-K | Current Report |
Oct 7, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
Sep 18, 2024 | SC 13D/A | [Amend] General statement of acquisition of beneficial ownership |
Sep 5, 2024 | S-8 | Securities to be offered to employees in employee benefit plans |